HIV and TB co-infections: latest updates and innovations

The webinar was hosted by IAS – the International AIDS Society – on 4 April 2023, provided updates on innovations in the treatment and prevention of HIV and tuberculosis (TB) co-infections, including the World Health Organization’s (WHO’s) recently published module in its consolidated guidelines on TB: drug-resistant tuberculosis treatment 2022 update. Participants will hear from MedAccess about an agreement to reduce the price of a recently announced alternative drug to treat multidrug-resistant TB and what this means for the treatment of HIV and TB. Finally, civil society representatives will share their experiences on integrated community engagement interventions and new innovative models of treatment for HIV and TB.

4 April 2023

Sean Wasserman

Associate Professor

Division of Infectious Diseases and HIV Medicine, University of Cape Town

Kenneth Ngure

Kenneth Ngure

Jomo Kenyatta University of Agriculture and Technology

Fuad Mirzayev

Fuad Mirzayev

Team Lead, TB treatment team

Prevention, Diagnosis, Treatment, Care and Innovation Unit (PCI) WHO Global TB Programme (GTB)

Updated WHO consolidated guidelines on DR-TB treatment 2022

Hema Srinivasan

Chief Access Officer


Market shaping to improve equitable access to drug-resistant TB treatment
Ashna Ashesh

Ashna Ashesh

MDR TB Survivor, Public Health Professional, Lawyer, Member, rGLC, SEA, WHO; and Fellow, SATB

Integrated community engagement interventions in HIV-TB
Wame Jallow

Wame Jallow

Vice President of International Programs

Population Media Center

The ‘whole-society’ & innovative models to treating co-infections